Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v9-EN
Language French English
Date Updated 2018-05-16 2018-05-16
Drug Identification Number 02188880 02188880
Brand name BREVIBLOC INJECTION 10MG/ML BREVIBLOC INJECTION 10MG/ML
Common or Proper name Brevibloc Injection Brevibloc Injection
Company Name BAXTER CORPORATION BAXTER CORPORATION
Ingredients ESMOLOL HYDROCHLORIDE ESMOLOL HYDROCHLORIDE
Strength(s) 10MG 10MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10mL vials 10mL vials
ATC code C07AB C07AB
ATC description BETA BLOCKING AGENTS BETA BLOCKING AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2018-03-09 2018-03-09
Actual start date 2018-03-27 2018-03-27
Estimated end date 2018-05-09 2018-05-09
Actual end date 2018-05-09 2018-05-09
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments For further questions regarding this product, please contact Baxter Customer Service at 1-888-719-9955 or Medical Information at 1-855-584-1368. For further questions regarding this product, please contact Baxter Customer Service at 1-888-719-9955 or Medical Information at 1-855-584-1368.
Health Canada comments